29.08.2025
To the attention of interested persons
NAMMDR – Specifications on establishing the level of compensation of some medicinal products
The National Agency for Medicines and Medical Devices of Romania (NAMMDR) has, according to the law, the responsibility to carry out the technical evaluation of medicinal products in order to establish, among other things, their level of compensation. This process is carried out according to the criteria provided by the legislative framework in force and follows the efficient use of the allocated funds, while ensuring patient access to safe and effective treatments.
The detailed reports issued by the NAMMDR are made public on the institution’s website and contain items which are necessary for the evaluation of the measures considered appropriate by the Ministry of Health and the National Health Insurance House (NHIH). Please note that NAMMDR evaluations represent a technical stage, scientifically and legally based, and that the practical implementation of any change in compensation levels shall be carried out as a result of an analysis which also involves a social-economic impact component, through decision of the Ministry of Health, with the consultation of the partners involved.
An analysis based on the updated data for year 2025 is currently unavailable; it is currently being developed.
The NAMMDR shall continue to offer its entire specialised support and to collaborate with the Ministry of Health and the National Health Insurance House, in order to ensure the fair access of patients to treatments and transparent and efficient use of the resources of the healthcare system.